Position in KYMR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$12,964,818
+$2,518,673 QoQ
Shares Held
113,062
-9.9% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 273 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in KYMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,920,143,201 across 425 Biotechnology names. KYMR ranks #77 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in KYMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,964,818 | 113,062 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $10,446,145 | 125,419 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $10,220,575 | 131,353 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $10,906,762 | 192,699 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $9,064,987 | 207,722 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,282,940 | 46,874 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,491,124 | 37,065 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $6,649,436 | 140,491 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $1,341,577 | 44,944 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $18,328,626 | 455,936 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $13,041,782 | 512,246 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $8,645,687 | 621,992 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $15,080,772 | 655,971 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $16,799,202 | 566,966 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $13,766,013 | 551,523 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $12,231,952 | 561,872 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,880,512 | 603,378 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $6,918,260 | 163,475 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $11,468,387 | 180,633 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,747,019 | 165,935 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,975,097 | 164,435 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $2,287,182 | 58,857 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $1,369,332 | 22,086 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||